Prognostic factors of patients with advanced lung cancer treated with anlotinib: a retrospective cohort study
Objective Our study aimed to evaluate the main factors affecting the efficacy of anlotinib to determine the therapeutically dominant populations. Methods The medical records of patients with lung cancer who were treated with anlotinib from July 2018 to February 2020 at Renji Hospital, School of Medi...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-10-01
|
Series: | Journal of International Medical Research |
Online Access: | https://doi.org/10.1177/03000605211046173 |